Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Oct 31;9(3):1429.
doi: 10.4022/jafib.1429. eCollection 2016 Oct-Nov.

Cryoballoon versus Radiofrequency Ablation for Atrial Fibrillation: A Meta-analysis of 16 Clinical Trials

Affiliations

Cryoballoon versus Radiofrequency Ablation for Atrial Fibrillation: A Meta-analysis of 16 Clinical Trials

Jalaj Garg et al. J Atr Fibrillation. .

Abstract

Introduction: We aimed to study the procedural characteristics, efficacy and safety of cryoballoon ablation (CBA) versus radiofrequency ablation (RFA) for catheter ablation of paroxysmal atrial fibrillation (AF). Methods: A systematic literature search was performed using PubMed, EMBASE, Web of Science, and Cochrane Central Register of Controlled Trials to clinical trials comparing CBA and RFA for AF. Outcomes were evaluated for efficacy, procedure characteristics and safety. For each study, odd ratio (OR) and 95% confidence intervals (CIs) were calculated for endpoints for both approaches. Results: We analyzed a total of 9,957 participants (3,369 in the CBA and 6,588 in RFA group) enrolled in 16 clinical trials. No significant difference was observed between CBA and RFA with regards to freedom from atrial arrhythmia at 12-months, recurrent atrial arrhythmias or repeat catheter ablation. CBA group had a significantly higher transient phrenic nerve injury (OR 14.19, 95% CI: 6.92-29.10; p<0.001) and persistent phrenic nerve injury (OR 4.62, 95% CI: 1.97-10.81; p<0.001); and a significantly lower pericardial effusion/cardiac tamponade (OR 0.43, 95% CI: 0.26-0.72; p=0.001), and groin site complications (OR 0.60, 95% CI: 0.38-0.93; p=0.02). No significant difference was observed in overall complications, stroke/thromboembolic events, major bleeding, and minor bleeding. Conclusion: CBA was non-inferior to RFA for catheter ablation of paroxysmal AF. RF ablation was associated with a higher groin complications and pericardial effusion/cardiac tamponade, whereas CBA was associated with higher rates of transient and persistent phrenic nerve injury.

Keywords: Atrial Fibrillation; Catheter Ablation; Cryoballoon; Radiofrequency.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.. Process of study selection for randomized and prospective trials
Supplementary Figure 1.
Supplementary Figure 1.. Funnel plots evaluating publication bias in all studies: a) Freedom from atrial arrhythmias at 12 months; b) Recurrent atrial arrhythmias; c) Repeat ablation within 12 months since index ablation; d) Overall acute complications
Figure 2.
Figure 2.. Forest plot demonstrating primary efficacy outcomes in patients with atrial fibrillation undergoing cryoablation versus radiofrequency ablation
Figure 3.
Figure 3.. Forest plot demonstrating procedural outcomes of cryoablation versus radiofrequency ablation
Figure 4.
Figure 4.. Forest plot demonstrating all-cause mortality in patients with atrial fibrillation undergoing cryoablation versus radiofrequency ablation
Figure 5A.
Figure 5A.. Forest plot demonstrating safety outcomes - overall acute complications, stroke/thromboembolism, major bleeding, minor bleeding and groin site complications in patients with atrial fibrillation undergoing cryoablation versus radiofrequency ablation
Figure 5B.
Figure 5B.. Forest plot demonstrating safety outcomes - transient and unresolved phrenic nerve injury, pericardial effusion/tamponade and pulmonary vein stenosis in patients with atrial fibrillation undergoing cryoablation versus radiofrequency ablation
Supplementary Figure 2.
Supplementary Figure 2.. Forest plot demonstrating primary efficacy endpoints (randomized controlled trials only) in patients with atrial fibrillation undergoing cryoablation versus radiofrequency ablation
Supplementary Figure 3.
Supplementary Figure 3.. Forest plot demonstrating procedural outcomes (randomized controlled trials only) in patients with atrial fibrillation undergoing cryoablation versus radiofrequency ablation
Supplementary Figure 4.
Supplementary Figure 4.. Forest plot demonstrating safety outcomes (randomized controlled trials only) - overall acute complications, groin site complications, transient and unresolved phrenic nerve injury and pericardial effusion/tamponade in patients with atrial fibrillation undergoing cryoablation versus radiofrequency ablation
Supplementary Figure 5.
Supplementary Figure 5.. Forest plot demonstrating primary efficacy endpoints in studies evaluating 2nd generation CBA catheter versus contact-sensing RFA catheter
Supplementary Figure 6.
Supplementary Figure 6.. Forest plot demonstrating procedural outcomes in studies evaluating 2nd generation CBA catheter versus contact-sensing RFA catheter
Supplementary Figure 7.
Supplementary Figure 7.. Forest plot demonstrating safety outcomes – overall acute complications, groin site complications and transient phrenic nerve injury in studies evaluating 2nd generation CBA catheter and contact-sensing RFA catheter

Similar articles

Cited by

References

    1. January Craig T, Wann L Samuel, Alpert Joseph S, Calkins Hugh, Cigarroa Joaquin E, Cleveland Joseph C, Conti Jamie B, Ellinor Patrick T, Ezekowitz Michael D, Field Michael E, Murray Katherine T, Sacco Ralph L, Stevenson William G, Tchou Patrick J, Tracy Cynthia M, Yancy Clyde W. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J. Am. Coll. Cardiol. 2014 Dec 02;64 (21):e1–76. - PubMed
    1. Colilla Susan, Crow Ann, Petkun William, Singer Daniel E, Simon Teresa, Liu Xianchen. Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. Am. J. Cardiol. 2013 Oct 15;112 (8):1142–7. - PubMed
    1. Cappato Riccardo, Calkins Hugh, Chen Shih-Ann, Davies Wyn, Iesaka Yoshito, Kalman Jonathan, Kim You-Ho, Klein George, Natale Andrea, Packer Douglas, Skanes Allan, Ambrogi Federico, Biganzoli Elia. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol. 2010 Feb;3 (1):32–8. - PubMed
    1. Calkins Hugh, Kuck Karl Heinz, Cappato Riccardo, Brugada Josep, Camm A John, Chen Shih-Ann, Crijns Harry J G, Damiano Ralph J, Davies D Wyn, DiMarco John, Edgerton James, Ellenbogen Kenneth, Ezekowitz Michael D, Haines David E, Haissaguerre Michel, Hindricks Gerhard, Iesaka Yoshito, Jackman Warren, Jalife Jose, Jais Pierre, Kalman Jonathan, Keane David, Kim Young-Hoon, Kirchhof Paulus, Klein George, Kottkamp Hans, Kumagai Koichiro, Lindsay Bruce D, Mansour Moussa, Marchlinski Francis E, McCarthy Patrick M, Mont J Lluis, Morady Fred, Nademanee Koonlawee, Nakagawa Hiroshi, Natale Andrea, Nattel Stanley, Packer Douglas L, Pappone Carlo, Prystowsky Eric, Raviele Antonio, Reddy Vivek, Ruskin Jeremy N, Shemin Richard J, Tsao Hsuan-Ming, Wilber David. 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace. 2012 Apr;14 (4):528–606. - PubMed
    1. Kuck Karl-Heinz, Brugada Josep, Fürnkranz Alexander, Metzner Andreas, Ouyang Feifan, Chun K R Julian, Elvan Arif, Arentz Thomas, Bestehorn Kurt, Pocock Stuart J, Albenque Jean-Paul, Tondo Claudio. Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial Fibrillation. N. Engl. J. Med. 2016 Jun 09;374 (23):2235–45. - PubMed

LinkOut - more resources